AIX Ventures

I'm thrilled to announce AIX Ventures' seed investment in Greenshoe, Inc., the first AI-native platform purpose-built to automate and elevate U.S. Securities and Exchange Commission (SEC) disclosures! The need for Greenshoe goes far beyond speeding up filings — it’s about restoring trust, accuracy, and agility in how companies communicate with the markets. Today’s disclosure process is fragmented across tools, teams, and templates, with every version, redline, and compliance cycle introducing new risk. In a market that moves in real time, the workflows behind these filings remain stuck in a manual, pre-AI world. Greenshoe changes this by treating disclosure as data, not documents. By integrating AI directly into the drafting, validation, and review process, filings become faster, more consistent, audit-ready, and far less error-prone — eliminating late-night scrambles, version-control chaos, and mismatched footnotes. We’re excited to partner with Payton McCoy, Dr. Yi Zhang, and the entire Greenshoe team as they modernize the very foundation of market transparency!

Congrats to the marimo & CoreWeave teams!

Congrats to Fan-Yun Sun, Sharon Lee, & the entire Moonlake AI team!

Check out the AIX Ventures HQ fireside chat with Tanay Kothari, Christopher Manning, & Shaun Johnson

This feels like an insane moment. Reid Hoffman just named our startup as the future of human-computer interaction. The founder of LinkedIn just told the world he's "voicepilled" and we're one of the reasons why. I've been building voice products since I was 11. Had 2.5 million users before I could legally sign contracts. But this moment? This is different. Reid wrote: "If you use products like Wispr Flow or ChatGPT Voice, you know what I mean... once you start seriously using your voice to interact with technology, you unlock a new way to amplify your ability." He's right. But here's what even Reid doesn't know: We almost killed the product 3 times. Voice is HARD. Everyone thinks the problem is accuracy. It's not. It's trust. When Reid says "voice is iterative by default - you stumble, you rephrase, you interrupt yourself" - that's exactly what we had to solve. Other tools transcribe your stumbles. We translate them into what you meant. When most LLMs hallucinate 2% of the time, we dropped ours to be 1 in a million. Rebuilt our entire pipeline from scratch. Twice. Why? Because professionals won't use voice if they have to edit every message. Reid called this moment being "voicepilled" - that clarity when you realize voice changes everything. For me, that moment came at 11 watching Iron Man. Tony Stark talking to Jarvis. 14 years later, we're actually building it. Thanks for believing in the vision, Reid. The future is voice-first.

🚨 HOT OFF THE PRESS 🚨 we just released our Q2 2025 State of the Bots report — analyzing AI bot and agent activity across the TollBit publisher network which include some of the world's biggest publishers. This report reveals some shocking trends: - New AI visitors look human: The latest AI browsers and devtools — like Perplexity Comet, Firecrawl, and Browserless — appear as Chrome in site logs, solve CAPTCHAs, and mimic human behavior. This is going to cause problems for advertising integrity. - RAG access reduces broken links: We analyze HTTP 404 status codes to find which AI platforms send visitors to the most broken or hallucinated links. - AI bot activity surpasses Bingbot: For the first time, aggregate AI bot traffic across publisher sites has overtaken crawls from the world’s #2 search engine. - Human visitors are falling, AI rising: From Q1 to Q2, human visits declined 9.4% across sites on TollBit. Meanwhile, AI visitors grew sharply — rising from 1 in 200 to 1 in 50 total site visits. - And many more insights across 75 pages! 👉 Download the full report here: https://lnkd.in/e8UYNeca

Today AIX Ventures is leading the $10M seed round for Therna Biosciences to develop generative AI models for designing programmable RNA medicines. Founded by the legendary Nazli Azimi and Hani Goodarzi, Therna's lab-in-the-loop approach and proprietary functional RNA models give the company a clear edge to engineer better RNA medicines, faster. Read more in Katherine Davis article for Axios: https://lnkd.in/ePMUrgvH